MEDI-8089 - USA (Washington, DC) - Prescription Drug Monitoring Program Service - Deadline September 30,2026

(1) Vendor needs to provide prescription drug monitoring program service to the government authority located in Washington, DC. • Support state and local governments to encourage the use to improve clinical decision–making and detecting and preventing the diversion and abuse of pharmaceutically controlled substances, such as opioids and other prescription drugs• Strengthen capacity of PDMPs to share information on prescribing, dispensing, and use of prescription drugs within and between states using preferred method of choice• Facilitate use of data to support law enforcement efforts, allocation of substance use disorder treatment and prevention resources, and sound clinical decision making among prescribers.• Design, implement, and advance initiatives to improve linkage, analysis, reporting, usage, and sharing of derived data.